Do you support chromosomal integration as well as plasmid-based expression?

Yes. The preferred architecture depends on the development objective. Plasmids can support rapid screening and flexible iteration, while integration can be evaluated when stable inheritance, lower copy-number variation, or reduced dependence on selective pressure is important.

How do you confirm that the secreted protein is functionally active?

Functional confirmation is tailored to the cargo. Depending on mechanism and available reagents, the plan may include receptor- or pathway-linked cell assays, biomarker measurements, immunological readouts, or other agreed assays that connect protein secretion with the intended biological effect.

Can stability testing be added after the lead clone is selected?

Yes. Genetic and phenotypic stability can be evaluated across defined passages or storage conditions. The study can track construct retention together with expression or secretion behavior so stability is assessed at both the genotype and functional-phenotype levels.

Can the same project continue into fermentation, formulation, or animal studies?

Yes. Once a lead recombinant strain is selected, the program can be extended into process development, formulation, dose-material preparation, biosafety-oriented studies, and preclinical animal evaluation. The handoff plan keeps key identity, expression, secretion, and stability checkpoints connected across stages.

Recombinant Lactobacillus casei Expressing an Akkermansia muciniphila-Secreted Protein Construction Service

Creative Biolabs builds recombinant Lactobacillus casei strains for secretion of Akkermansia muciniphila-derived protein cargo, integrating payload and signal-peptide design, expression architecture, clone screening, secretion confirmation, and functional testing. The service helps engineered-probiotic teams balance protein output, folding, host fitness, stability, and downstream development needs within one coordinated construction program.

Engineering a Secretion-Competent L. casei Protein Delivery Chassis

Engineered-probiotic programs that use L. casei to deliver a protein derived from A. muciniphila must solve more than gene insertion. Protein yield, secretion efficiency, folding, proteolytic stability, host growth, and genetic burden can shift together, so an apparently strong construct may lose performance once the strain is cultured, stored, or moved into a biological assay.

Creative Biolabs converts that multidimensional problem into a staged construction and characterization plan. We coordinate cargo sequence review, secretion-signal selection, plasmid or genome-integration strategy, clone generation, expression and secretion confirmation, functional assays, genetic stability, biosafety-oriented characterization, and handoff to process or animal studies so teams can advance a strain supported by linked molecular and functional evidence.

Cas9D10A nickase-assisted recombineering workflow in Lactobacillus casei — CRISPR-Cas9^D10A nickase-assisted recombineering illustrates a practical route for targeted *L. casei* strain engineering.²

Recombinant L. casei Construction and Secreted-Protein Validation Services

Our program is designed around the actual development question: can the selected L. casei chassis produce and release the intended A. muciniphila-derived protein at a useful level while maintaining strain fitness, reproducibility, and downstream usability?

Payload and Secretion-Signal Design

We review the coding sequence, mature-protein boundaries, optional tags, linker needs, codon usage, secretion route, and signal-peptide candidates. Design choices are evaluated together because a signal peptide that increases export can still compromise precursor processing, protein folding, or host fitness.

Payload sequence and domain-boundary review
Signal-peptide and secretion-route selection
Codon optimization and expression-cassette planning
Tag, linker, cleavage-site, and detection strategy

Vector or Genome-Integration Strategy

The expression architecture is matched to project priorities such as speed, copy-number control, antibiotic-marker constraints, or long-term stability. Plasmid-based construction can support rapid prototyping, while genomic integration can be considered when stable inheritance and reduced selective pressure are higher priorities.

Promoter and regulatory-element selection
Plasmid construction or chromosomal integration planning
Gene knock-in, insertion, or supporting host edits
Sequence-confirmed construct architecture

Strain Construction and Clone Screening

Candidate strains are generated and screened using molecular confirmation plus phenotype-aware ranking. Rather than selecting a clone only from DNA-level success, we can compare growth, expression, secretion, and basic fitness indicators so weak or burdensome designs are identified early.

Transformation or editing and colony recovery
PCR and sequencing validation
Clone-to-clone expression comparison
Growth and host-burden observations

Expression, Secretion, and Functional Confirmation

We distinguish total expression from extracellular delivery and can build a layered analytical package around the intended mechanism. Western blotting, PAGE, immunoassays, targeted quantification, and project-specific cell assays can be combined to show whether the secreted material is detectable and functionally relevant.

Cell-associated versus supernatant analysis
Protein identity and relative abundance assessment
Optional folding- or activity-relevant assays
Mechanism-linked cell-based functional testing

Development Characterization Beyond Initial Construction

Genetic and Phenotypic Stability

Track construct retention, expression behavior, and key phenotype markers across defined passages or storage conditions to understand whether the engineered trait remains consistent.

Biosafety-Oriented Characterization

Integrate strain identity, relevant antibiotic susceptibility or resistance profiling, contaminant control, and other agreed safety-supporting tests appropriate to the research stage.

Process and Animal-Study Handoff

Carry the selected clone into fermentation, formulation, dose-material preparation, or preclinical animal planning with analytical checkpoints linked back to the construction-stage phenotype.

Recombinant L. casei Construction Workflow

Each stage feeds the next decision, allowing design assumptions to be tested before the program advances into more expensive characterization or preclinical work.

Define Cargo and Success Criteria

Confirm protein sequence, intended biological function, secretion requirement, host strain, analytical endpoints, and downstream use.

Design Expression Architecture

Select signal peptide, promoter, vector or integration route, detection elements, and supporting sequence features.

Construct and Confirm Clones

Generate recombinant strains, recover candidates, and verify the intended genetic architecture by molecular methods.

Screen Expression and Secretion

Compare candidate clones for protein production, extracellular release, growth behavior, and reproducibility.

Validate Function and Stability

Apply project-specific activity assays and stability studies to connect molecular expression with development-relevant performance.

Prepare Downstream Handoff

Package the selected strain, supporting data, and recommendations for process optimization, formulation, biosafety work, or animal studies.

Deliverables for Engineered L. casei Protein-Secretion Programs

The exact package is tailored to the construct and study stage, with optional modules added only when they answer a defined development question.

Development Area	Typical Outputs	Decision Supported
Design	Payload and signal-peptide plan, construct map, sequence design	Choose an expression strategy that balances secretion and host burden
Construction	Sequence-confirmed recombinant strain, glycerol stock, clone records	Establish a traceable engineered starting material
Protein Evidence	Expression and secretion results using agreed analytical methods	Differentiate genetic success from productive secretion
Functional Evidence	Mechanism-linked or cell-based activity data where applicable	Confirm that secreted cargo retains relevant biological activity
Stability and Safety Support	Passage/stability observations and selected safety-oriented test results	Assess whether the engineered phenotype is suitable for next-stage work
Handoff	Study summary, recommended next tests, strain and sample package	Move efficiently into fermentation, formulation, or animal evaluation

Published Data Supporting Recombinant L. casei Protein Expression

Recent research demonstrates that recombinant L. casei can be engineered to produce heterologous protein cargo and can carry that construct into downstream biological evaluation. In the reported study, recombinant expression plasmids were verified and a secreted recombinant protein was detected from the culture supernatant of an engineered L. casei strain before the candidate was advanced into functional immune-response testing. This sequence of genetic confirmation, protein-level evidence, and biological evaluation mirrors the evidence chain needed for a secretion-focused chassis program.

The published data also show why construction should not stop at a positive clone. Downstream readouts distinguished the engineered L. casei candidate from comparator preparations, linking strain engineering to measurable biological performance. Creative Biolabs applies the same development logic to A. muciniphila-derived protein programs: confirm the construct, verify secretion, evaluate function, and then assess stability and downstream readiness rather than relying on a single expression endpoint.

Neutralizing antibody response after recombinant Lactobacillus casei candidate immunization. (OA Literature) — Fig.1 The neutralizing antibody levels of candidate vaccines in the serum of immunized mice.^1,3

Why Choose Creative Biolabs for Recombinant L. casei Development?

Integrated Strain-to-Function Planning

Construction, protein analysis, functional testing, stability, and downstream study design can be linked through one project plan, reducing disconnects between molecular engineering and preclinical decisions.

Design Choices Matched to Project Stage

Rapid plasmid prototyping, genomic integration, secretion optimization, and supporting host edits can be selected according to the program's speed, stability, and characterization priorities.

Analytical Flexibility

Sequencing, PAGE, Western blotting, immunoassays, and cell-based functional assays can be configured around the cargo and mechanism rather than forcing every program into a fixed panel.

Downstream Continuity

Selected strains can be transitioned into genetic stability studies, bioprocess and formulation development, biosafety characterization, and preclinical animal work as the evidence package matures.

Recommended Services for Engineered Probiotic Development

Extend strain construction with complementary engineering, stability, and process-development support as project requirements evolve.

Unleashing the Power Within: Probiotic Genetic Modification Service

Engineered Probiotics: Surface Display Solution for Targeted Application

Gene Integration Stability Test Service for Recombinant Strains

Engineered Probiotics: Full-Spectrum Bioprocess & Formulation Solution

Frequently Asked Questions

Yes. The study can distinguish cell-associated protein from secreted protein and compare design variables such as signal peptide, promoter strength, copy-number strategy, and construct architecture. This helps identify whether low extracellular protein reflects poor expression, inefficient export, degradation, or excessive burden on the host.

Other Resources

Creative Biolabs' Live Biotherapeutics - Brochure

Probiotic Strain Products for NGP Research - Brochure

Custom Small-scale Probiotic Production - Brochure

Live Biotherapeutics - Creative Biolabs - Video

Construction of Lactococcus lactis strain expressing A enzyme

Gene Knock-out and Knock-in in Escherichia coli Nissle 1917 Strain

References

Li, Xiaowen, et al. "The construction of recombinant Lactobacillus casei vaccine of PEDV and its immune responses in mice." BMC Veterinary Research 17.1 (2021): 184. https://doi.org/10.1186/s12917-021-02885-y
Song, Xin, et al. "CRISPR-Cas9^D10A nickase-assisted genome editing in Lactobacillus casei." Applied and Environmental Microbiology 83.22 (2017): e01259-17. https://doi.org/10.1128/AEM.01259-17
Distributed under Open Access license CC BY 4.0, without modification.

Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.